BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7656612)

  • 1. Comparing FEV1 in adults in two community-based studies.
    Xu X; Weiss ST; Dockery DW; Schouten JP; Rijcken B
    Chest; 1995 Sep; 108(3):656-62. PubMed ID: 7656612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cigarette smoking on rate of loss of pulmonary function in adults: a longitudinal assessment.
    Xu X; Dockery DW; Ware JH; Speizer FE; Ferris BG
    Am Rev Respir Dis; 1992 Nov; 146(5 Pt 1):1345-8. PubMed ID: 1443894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age, period, and cohort effects on pulmonary function in a 24-year longitudinal study.
    Xu X; Laird N; Dockery DW; Schouten JP; Rijcken B; Weiss ST
    Am J Epidemiol; 1995 Mar; 141(6):554-66. PubMed ID: 7900723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smoking, changes in smoking habits, and rate of decline in FEV1: new insight into gender differences.
    Xu X; Weiss ST; Rijcken B; Schouten JP
    Eur Respir J; 1994 Jun; 7(6):1056-61. PubMed ID: 7925873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decline in FEV1 and airflow limitation related to occupational exposures in men of an urban community.
    Humerfelt S; Gulsvik A; Skjaerven R; Nilssen S; Kvåle G; Sulheim O; Ramm E; Eilertsen E; Humerfelt SB
    Eur Respir J; 1993 Sep; 6(8):1095-103. PubMed ID: 8224123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal and cross-sectional estimates of pulmonary function decline in never-smoking adults.
    Ware JH; Dockery DW; Louis TA; Xu XP; Ferris BG; Speizer FE
    Am J Epidemiol; 1990 Oct; 132(4):685-700. PubMed ID: 2403109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heavy habitual marijuana smoking does not cause an accelerated decline in FEV1 with age.
    Tashkin DP; Simmons MS; Sherrill DL; Coulson AH
    Am J Respir Crit Care Med; 1997 Jan; 155(1):141-8. PubMed ID: 9001303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influence of smoking on longitudinal decline in one-second forced expiratory volume in clinically healthy Japanese men: a longitudinal study].
    Nishitsuji M; Fujimura M; Oribe Y; Kimura H; Nomura S; Yoshimoto A; Yoshimi Y; Kita T; Yasui M; Kasahara K; Nakao S
    Nihon Kokyuki Gakkai Zasshi; 2003 Oct; 41(10):691-5. PubMed ID: 14584387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does educational level influence lung function decline (Doetinchem Cohort Study)?
    Tabak C; Spijkerman AM; Verschuren WM; Smit HA
    Eur Respir J; 2009 Oct; 34(4):940-7. PubMed ID: 19541713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung function decline over 25 years of follow-up among black and white adults in the ARIC study cohort.
    Mirabelli MC; Preisser JS; Loehr LR; Agarwal SK; Barr RG; Couper DJ; Hankinson JL; Hyun N; Folsom AR; London SJ
    Respir Med; 2016 Apr; 113():57-64. PubMed ID: 26905512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of short-term decline of forced expiratory volume in 1 s over height cubed (FEV
    Hegendörfer E; Vaes B; Matheï C; Van Pottelbergh G; Degryse JM
    Aging Clin Exp Res; 2018 May; 30(5):507-516. PubMed ID: 28653254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of smoking and smoking cessation on longitudinal decline in pulmonary function.
    Burchfiel CM; Marcus EB; Curb JD; Maclean CJ; Vollmer WM; Johnson LR; Fong KO; Rodriguez BL; Masaki KH; Buist AS
    Am J Respir Crit Care Med; 1995 Jun; 151(6):1778-85. PubMed ID: 7767520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal analysis of the effects of smoking onset and cessation on pulmonary function.
    Sherrill DL; Holberg CJ; Enright PL; Lebowitz MD; Burrows B
    Am J Respir Crit Care Med; 1994 Mar; 149(3 Pt 1):591-7. PubMed ID: 8118623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of smoking on the decline in forced expiratory volume in one second].
    Sato K; Kioi S; Arakawa M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Mar; 35(3):288-93. PubMed ID: 9168644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group.
    Vestbo J; Prescott E; Lange P
    Am J Respir Crit Care Med; 1996 May; 153(5):1530-5. PubMed ID: 8630597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Declining FEV1 and chronic productive cough in cigarette smokers: a 25-year prospective study of lung cancer incidence in Tecumseh, Michigan.
    Islam SS; Schottenfeld D
    Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):289-98. PubMed ID: 8061576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A longitudinal study of plasma cortisol concentration and pulmonary function decline in men. The Normative Aging Study.
    Sparrow D; O'Connor GT; Rosner B; DeMolles D; Weiss ST
    Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1345-8. PubMed ID: 8503543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decline of lung function and development of chronic airflow limitation: a longitudinal study of non-smokers and smokers in Busselton, Western Australia.
    Peat JK; Woolcock AJ; Cullen K
    Thorax; 1990 Jan; 45(1):32-7. PubMed ID: 2321175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weight gain and longitudinal changes in lung function in steel workers.
    Wang ML; McCabe L; Petsonk EL; Hankinson JL; Banks DE
    Chest; 1997 Jun; 111(6):1526-32. PubMed ID: 9187168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Change in C-reactive protein levels and FEV1 decline: a longitudinal population-based study.
    Shaaban R; Kony S; Driss F; Leynaert B; Soussan D; Pin I; Neukirch F; Zureik M
    Respir Med; 2006 Dec; 100(12):2112-20. PubMed ID: 16650972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.